Investigation of Novel and Established Therapies in a Human Intravenous Lipopolysaccharide Model of Sepsis

NCT06626984 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Sepsis
Fluid Overload
Endothelial Dysfunction
Microcirculation

Interventions

DRUG: Imatinib
DRUG: Compound sodium lactate solution

Sponsor

Belfast Health and Social Care Trust

Collaborators

[object Object]
[object Object]